SNY - Sanofi Charts, Trade Ideas, Earnings, Ratings

TRENDING : Top 50 SPY (1.48%) TVIX (-10.7%) TSLA (2%) TLRA (-0.26%) RKDA (-18.43%) PYPL (1.16%) PG (1.53%) PFE (0.5%) NVS (1.01%) MSFT (1.84%) MRK (1.92%) MCD (0.1%) JMIA (-1.51%) IRBT (2.31%) GOOGL (0.85%) GE (9.74%) FB (0.61%) ETHUSD (%) EKSO (1.5%) DIS (1.35%) CVX (0.05%) CVNA (0.68%) BTCUSD (%) BBY (2.43%) BAC (2.98%)

SNY - Sanofi

$42.02 0.37[0.89%]

15 mins delayed data

People also watch :

+Watchlist

2 StockHoot Traders following this.
Analyst Ratings | Earnings

Previous Close	$41.65	Open	$41.82
Volume	976.5K	Market Cap	101.888B
Yield		Last Dividend

Day

52 Week

Regeneron Gets FDA Nod for Eylea Injecti...	08/15/19
Regeneron (REGN) receives FDA approval for a prefilled syringe of its ophthalmology drug, Eylea.

Should Value Investors Consider Sanofi (...	08/14/19
Let's see if Sanofi (SNY) stock is a good choice for value-oriented investors right now from multiple angles.

Does Sanofi's (EPA:SAN) CEO Pay Matt...	08/13/19
In 2015 Olivier Brandicourt was appointed CEO of Sanofi (EPA:SAN). First, this article will compare CEO compensation...

J&J's Tuberculosis Drug Gets FDA...	08/12/19
FDA approves J&J's (JNJ) pulmonary multidrug-resistant tuberculosis tablet Sirturo (bedaquiline) for the treatment of adolescent patients.

No-deal Brexit could deepen Europe's...	08/11/19
As the Oct. 31 deadline for Britain to leave the European Union approaches, health professionals are warning that shortages of some medicines could w...

Inovio (INO) Q2 Earnings & Revenues ...	08/09/19
Inovio Pharmaceuticals (INO) disappoints with earnings and revenue miss in the second quarter. Shares depreciate in after-hours trading.

Pharma Stock Roundup: AGN, NVO Earnings,...	08/09/19
Allergan (AGN) and Novo Nordisk (NVO) report Q2 results. AbbVie's (ABBV) Maviret and Sanofi's (SNY) Dupixent receive approval for new patient ...

MyoKardia, Inc. (MYOK) Q2 2019 Earnings ...	08/08/19
MYOK earnings call for the period ending June 30, 2019.

3 Dividend Stocks That Pay You More Than...	08/07/19
Sanofi, Realty Income, and Dick's Sporting Goods might just serve up more refreshing returns than the beverage giant.

Alnylam's (ALNY) Q2 Earnings and Rev...	08/07/19
Alnylam (ALNY) incurs wider-than-expected loss and misses sales estimates in the second quarter of 2019.

Regeneron Pharmaceuticals Reports Marked...	08/06/19
Revenue and earnings beat Wall Street estimates thanks to solid growth for Eylea and Dupixent.

ANALYST RATINGS

0 analyst ratings (Last 6 months)

0.00 %

Strong Buy + Buy

Price Target (PT)

EARNINGS

Date	04/12/2019 (AMC)	Est. (EPS/Rev.)	$1.37
Actual (EPS/Rev.)	$2.5B	EPS (TTM)	$???

TRADERS TRACKING $SNY

Service Name	Trader	% Success
Kiplinger - JAMES K. GLASSMAN	StockHoot	70.00 %	Follow
1035even	Evan Earle	61.00 %	Follow

SHOW ALL TRADERS

About Us

Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.

Product Types

Strategies

Follow Us

Secure Payments

We are not a registered investment advisor. All investments involve risk, individual's trading does not guarantee future results or returns. Investors are fully responsible for any investment decisions they make. References to specific securities should not be construed as a recommendation to buy or sell that security only mentioned for informational purposes.